Anti-Cancer Effects of Sulfasalazine and Vitamin E Succinate in MDA-MB 231 Triple-Negative Breast Cancer Cells
Abstract
Aim: Sulfasalazine (SSZ) displayed anti-cancer activities. Vitamin E succinate (VES) could inhibit cell
growth in various cancer cells. However, chemical therapies were often not useful for
triple-negative breast cancer cells (TNBCs) treatment. Here, this study investigated the anti-cancer
effects and the mechanisms on TNBCs under combination treatment with SSZ and VES.
Methods: Cell viability was analyzed by using the MTT assay. The H2O2 levels were determined by
using lucigenin-amplified chemiluminescence method. In addition, caspase and MAPs signals were
studied by using western blotting.
Results: Low-dose VES antagonized the SSZ-induced cytotoxicity effects while high-dose VES
promoted the SSZ-induced cytotoxicity effects on TNBCs. In addition, SSZ alone treatment
activated both caspase-3 and ERK signals, however, VES alone treatment only activated JNK signals.
On the other hand, activation of caspase-3, JNK, and ERK were found in SSZ plus VES-treated cells.
Conclusion: Combined SSZ and VES has synergistic or antagonistic cytotoxic effects depending on
VES concentration. In addition, different cytotoxic signals are induced on SSZ-treated, VES-treated
and SSZ plus VES-treated cells.